000			02220 a2200649 4500
005			20250518073429.0
264		0	_c20200710
008			202007s 0 0 eng d
022			_a1528-0012
024	7		_a10.1053/j.gastro.2019.11.296 _2doi
040			_aNLM _beng _cNLM
100	1		_aChalasani, Naga
245	0	0	_aEffects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension. _h[electronic resource]
260			_bGastroenterology _c04 2020
300			_a1334-1345.e5 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aBiopsy
650	0	4	_aBlood Proteins
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aGalectin 3 _xantagonists & inhibitors
650	0	4	_aGalectins
650	0	4	_aHumans
650	0	4	_aHypertension, Portal _xdiagnosis
650	0	4	_aInfusions, Intravenous
650	0	4	_aLiver _xdrug effects
650	0	4	_aLiver Cirrhosis _xdiagnosis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNon-alcoholic Fatty Liver Disease _xcomplications
650	0	4	_aPectins _xadministration & dosage
650	0	4	_aPlacebos _xadministration & dosage
650	0	4	_aPortal Pressure _xdrug effects
650	0	4	_aSeverity of Illness Index
650	0	4	_aTreatment Outcome
700	1		_aAbdelmalek, Manal F
700	1		_aGarcia-Tsao, Guadalupe
700	1		_aVuppalanchi, Raj
700	1		_aAlkhouri, Naim
700	1		_aRinella, Mary
700	1		_aNoureddin, Mazen
700	1		_aPyko, Maxmillan
700	1		_aShiffman, Mitchell
700	1		_aSanyal, Arun
700	1		_aAllgood, Adam
700	1		_aShlevin, Harold
700	1		_aHorton, Rex
700	1		_aZomer, Eliezer
700	1		_aIrish, William
700	1		_aGoodman, Zachary
700	1		_aHarrison, Stephen A
700	1		_aTraber, Peter G
773	0		_tGastroenterology _gvol. 158 _gno. 5 _gp. 1334-1345.e5
856	4	0	_uhttps://doi.org/10.1053/j.gastro.2019.11.296 _zAvailable from publisher's website
999			_c30396489 _d30396489